BRAF and glioblastoma: Postoperative pathology confirmed a high-grade glioblastoma with primitive neuroepithelial and focal spindle cell sarcoma components (Figure 1C), characterized by BRAF V600E mutation, WHO grade IV astrocytoma, and MGMT promoter methylation.